Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial
Diabetes Technology & Therapeutics · 2023-10 · 25 (10) · 677-688
DOI: 10.1089/dia.2023.0304 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 12.10.2023. Verfasst von Georgia M Davis und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetic Ketoacidosis, Hypoglycemia. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Multiple daily injection insulin therapy frequently fails to meet hospital glycemic goals and is prone to hypoglycemia. Automated insulin delivery (AID) with remote glucose monitoring offers a solution to these shortcomings. Research Design and Methods: In a single-arm multicenter pilot trial, we tested the feasibility, safety, and effectiveness of the Omnipod 5 AID System with real-time continuous glucose monitoring (CGM) for up to 10 days in hospitalized patients with insulin-requiring diabetes on nonintensive care unit medical–surgical units. Primary endpoints included the proportion of time in automated mode and percent time-in-range (TIR 70–180 mg/dL) among participants with >48 h of CGM data. Safety endpoints included incidence of severe hypoglycemia and diabetes-related ketoacidosis (DKA). Additional glycemic endpoints, CGM accuracy, and patient satisfaction were also explored.
Results
Twenty-two participants were enrolled; 18 used the system for a total of 96 days (mean 5.3 ± 3.1 days per patient), and 16 had sufficient CGM data required for analysis. Median percent time in automated mode was 95% (interquartile range 92%–98%) for the 18 system users, and the 16 participants with >48 h of CGM data achieved an overall TIR of 68% ± 16%, with 0.17% ± 0.3% time
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
- Division of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University, Stanford, California, USA.
- Division of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
- Jaeb Center for Health Research, Tampa, Florida, USA.
- Insulet Corporation, Acton, Massachusetts, USA.
- Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, California, USA.
ORCID-Profile: Michael S Hughes, Trang T Ly, Roy W Beck, Rayhan Lal, Francisco J Pasquel
Förderung
- NIGMS NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Davis, G. M., Hughes, M. S., Brown, S. A., Sibayan, J., Perez-Guzman, M. C., Stumpf, M., Thompson, Z., Basina, M., Patel, R. M., Hester, J., Abraham, A., Ly, T. T., Chaney, C., Tan, M., Hsu, L., Kollman, C., Beck, R. W., Lal, R., Buckingham, B., & Pasquel, F. J. (2023). Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial. Diabetes Technology & Therapeutics, 25(10), 677-688. https://doi.org/10.1089/dia.2023.0304
Vancouver
Davis GM, Hughes MS, Brown SA, Sibayan J, Perez-Guzman MC, Stumpf M, et al. Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial. Diabetes Technology & Therapeutics. 2023;25(10):677-688. doi:10.1089/dia.2023.0304
BibTeX
@article{Davis2023,
author = {Davis, Georgia M and Hughes, Michael S and Brown, Sue A and Sibayan, Judy and Perez-Guzman, M Citlalli and Stumpf, Meaghan and Thompson, Zachary and Basina, Marina and Patel, Ronak M and Hester, Joi and Abraham, Amalia and Ly, Trang T and Chaney, Cherie and Tan, Marilyn and Hsu, Liana and Kollman, Craig and Beck, Roy W and Lal, Rayhan and Buckingham, Bruce and Pasquel, Francisco J},
title = {Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
volume = {25},
number = {10},
pages = {677--688},
doi = {10.1089/dia.2023.0304}
}
EUVIMED